Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
---|---|---|---|---|---|---|---|---|
Jan 28, 2020 | Jan 31, 2020 | Van Deventer Sander EVP Research Product Dev. | Sell | Uniqure N.V. | QURE | $61.61 | $137,214 | -4.03% |
Jan 28, 2019 | Jan 30, 2019 | Van Deventer Sander Chief Scientific Officer | Sell | Uniqure N.V. | QURE | $31.31 | $42,519 | -3.26% |
Jan 29, 2018 | Jan 31, 2018 | Van Deventer Sander Chief Scientific Officer | Sell | Uniqure N.V. | QURE | $18.53 | $110,902 | -19.27% |
Aug 02, 2016 | Aug 04, 2016 | Van Deventer Sander Dir 10% | Buy | Argos Therapeutics Inc | ARGS | ~ | $0 | +19.95% |
Jun 29, 2016 | Jul 01, 2016 | Van Deventer Sander Dir 10% | Buy | Argos Therapeutics Inc | ARGS | ~ | $0 | +22.13% |
Mar 14, 2016 | Mar 16, 2016 | Van Deventer Sander Dir 10% | Buy | Argos Therapeutics Inc | ARGS | ~ | $0 | +20.93% |
Feb 12, 2014 | Feb 12, 2014 | Van Deventer Sander Dir 10% | Buy | Argos Therapeutics Inc | ARGS | $8 | $291,328 | +1.46% |
- 1/1
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.